Ling Liu
Nanjing, Jiangsu, 210009, China
NCT Number: NCT04754113
A prospective physiologic study, in participants with COVID-19-related pneumonia requiring supplemental oxygen (standard oxygen therapy or high-flow nasal cannula (HFNC)) less than 24 hours. The investigators assessed the effect of prone position on ventilation inhomogeneity and ventilation/perfusion mismatch by electrical impedance tomography (EIT).
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Nanjing, Jiangsu, 210009, China
Once enrolled, an EIT dedicated belt containing 16 electrodes was placed around the participant's chest at the fifth or sixth intercostal space and connected it to an EIT monitor (PulmoVista 500; Dräger Medical GmbH, Lübeck, Germany).
Baseline data were collected during supine position (timepoint SP1), including demographic and anthropometric data, a baseline arterial blood gas measurement, and ventilation parameters including type of supplemental oxygen, respiratory rate, fractional concentration of oxygen in inspired air (FiO2). The participants received instructions of end expiratory occlusion lasting at least 10 seconds and, 1 seconds after the start, a bolus of 10 mL of 5% NaCl solution was injected via the central venous catheter. Subsequently, each participant was helped into the prone position and data collection,end expiratory occlusion and 10% NaCl solution injection were preformed again after approximately 30 min (timepoint PP1). The participant was then encouraged to maintain the prone position for at least 3 h before being helped back into the supine position. Clinical data collection, end expiratory occlusion and injection of a bolus of 10 mL of 5% NaCl solution were repeated again 1 h after resupination (timepoint SP2).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patient was helped into the prone position, patient received instructions of end expiratory occlusion lasting at least 10 seconds and, 1 seconds after the start, a bolus of 10 mL of 5% NaCl solution was injected via the central venous catheter
Time frame: prone position 1 hour
V/Q mismatch was quantified as the percentage of pixels that were classified as ventilated but not perfused (dead space fraction) plus the percentage of those perfused but not ventilated (shunt fraction).
Time frame: resupination 1 hour
V/Q mismatch was quantified as the percentage of pixels that were classified as ventilated but not perfused (dead space fraction) plus the percentage of those perfused but not ventilated (shunt fraction).
Time frame: Baseline,prone position 1hour, resupination 1 hour
The percentage of relative pixel-level ventilation (Vpixel) distending dorsal lung regions at each study phase
Time frame: Baseline,prone position 1hour, resupination 1 hour
The pixel-level relative regional pulmonary perfusion
Time frame: Baseline,prone position 1hour, resupination 1 hour
higher values indicating less homogenous ventilation
Time frame: Baseline,prone position 1hour, resupination 1 hour
PaO2/FiO2
Southeast University, China
Other
Effect of Prone Position on Lung Ventilation and Perfusion Matching in Non-intubated Patients With COVID-19 Pneumonia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05777720
COVID-19, Coronaviridae Infections
San Mateo, California, United States
View Trial DetailsNCT04473105
COVID-19, Coronaviridae Infections
Nottingham, United Kingdom
View Trial DetailsNCT04844580
COVID-19, Coronaviridae Infections
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04860206
COVID-19, Cognition Disorders
Izola, Slovenia
View Trial Details